Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect ...
A lack of plasma antibodies against late-liver-stage antigens (PfAMA1 and PfMSP1) indicates that exposure to those antigens is insufficient to mount a measurable antibody response. A data sharing ...